Report cover image

Global Terlipressin Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 185 Pages
SKU # APRC20553046

Description

Summary

According to APO Research, The global Terlipressin market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Terlipressin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Terlipressin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Terlipressin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Terlipressin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Terlipressin include Sun Pharmaceutical Industries Ltd., Hangzhou Huadi Group, Hybio Pharmaceutical, Xi 'an langene biological technology, Shanghai Soho-Yiming Pharmaceuticals, SGPharma, Maya Biotech and EVER Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Terlipressin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Terlipressin, also provides the sales of main regions and countries. Of the upcoming market potential for Terlipressin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Terlipressin sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Terlipressin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Terlipressin sales, projected growth trends, production technology, application and end-user industry.

Terlipressin Segment by Company

Sun Pharmaceutical Industries Ltd.
Hangzhou Huadi Group
Hybio Pharmaceutical
Xi 'an langene biological technology
Shanghai Soho-Yiming Pharmaceuticals
SGPharma
Maya Biotech
EVER Pharma
Terlipressin Segment by Type

5ml vial Injections
10mL vial Injections
Terlipressin Segment by Application

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Terlipressin Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Terlipressin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Terlipressin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Terlipressin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Terlipressin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Terlipressin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Terlipressin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Terlipressin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

185 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Terlipressin Market Size, 2020 VS 2024 VS 2031
1.3 Global Terlipressin Market Size Estimates and Forecasts (2020-2031)
1.4 Global Terlipressin Sales Estimates and Forecasts (2020-2031)
1.5 Global Terlipressin Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Terlipressin Market Dynamics
2.1 Terlipressin Industry Trends
2.2 Terlipressin Industry Drivers
2.3 Terlipressin Industry Opportunities and Challenges
2.4 Terlipressin Industry Restraints
3 Terlipressin Market by Manufacturers
3.1 Global Terlipressin Revenue by Manufacturers (2020-2025)
3.2 Global Terlipressin Sales by Manufacturers (2020-2025)
3.3 Global Terlipressin Average Sales Price by Manufacturers (2020-2025)
3.4 Global Terlipressin Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Terlipressin Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Terlipressin Manufacturers, Product Type & Application
3.7 Global Terlipressin Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Terlipressin Market CR5 and HHI
3.8.2 Global Top 5 and 10 Terlipressin Players Market Share by Revenue in 2024
3.8.3 2024 Terlipressin Tier 1, Tier 2, and Tier 3
4 Terlipressin Market by Type
4.1 Terlipressin Type Introduction
4.1.1 5ml vial Injections
4.1.2 10mL vial Injections
4.2 Global Terlipressin Sales by Type
4.2.1 Global Terlipressin Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Terlipressin Sales by Type (2020-2031)
4.2.3 Global Terlipressin Sales Market Share by Type (2020-2031)
4.3 Global Terlipressin Revenue by Type
4.3.1 Global Terlipressin Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Terlipressin Revenue by Type (2020-2031)
4.3.3 Global Terlipressin Revenue Market Share by Type (2020-2031)
5 Terlipressin Market by Application
5.1 Terlipressin Application Introduction
5.1.1 Hospital Pharmacies
5.1.2 Retail Pharmacies
5.1.3 Online Pharmacies
5.2 Global Terlipressin Sales by Application
5.2.1 Global Terlipressin Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Terlipressin Sales by Application (2020-2031)
5.2.3 Global Terlipressin Sales Market Share by Application (2020-2031)
5.3 Global Terlipressin Revenue by Application
5.3.1 Global Terlipressin Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Terlipressin Revenue by Application (2020-2031)
5.3.3 Global Terlipressin Revenue Market Share by Application (2020-2031)
6 Global Terlipressin Sales by Region
6.1 Global Terlipressin Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Terlipressin Sales by Region (2020-2031)
6.2.1 Global Terlipressin Sales by Region (2020-2025)
6.2.2 Global Terlipressin Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Terlipressin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Terlipressin Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Terlipressin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Terlipressin Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Terlipressin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Terlipressin Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Terlipressin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Terlipressin Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Terlipressin Revenue by Region
7.1 Global Terlipressin Revenue by Region
7.1.1 Global Terlipressin Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Terlipressin Revenue by Region (2020-2025)
7.1.3 Global Terlipressin Revenue by Region (2026-2031)
7.1.4 Global Terlipressin Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Terlipressin Revenue (2020-2031)
7.2.2 North America Terlipressin Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Terlipressin Revenue (2020-2031)
7.3.2 Europe Terlipressin Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Terlipressin Revenue (2020-2031)
7.4.2 Asia-Pacific Terlipressin Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Terlipressin Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Terlipressin Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Sun Pharmaceutical Industries Ltd.
8.1.1 Sun Pharmaceutical Industries Ltd. Comapny Information
8.1.2 Sun Pharmaceutical Industries Ltd. Business Overview
8.1.3 Sun Pharmaceutical Industries Ltd. Terlipressin Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Sun Pharmaceutical Industries Ltd. Terlipressin Product Portfolio
8.1.5 Sun Pharmaceutical Industries Ltd. Recent Developments
8.2 Hangzhou Huadi Group
8.2.1 Hangzhou Huadi Group Comapny Information
8.2.2 Hangzhou Huadi Group Business Overview
8.2.3 Hangzhou Huadi Group Terlipressin Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Hangzhou Huadi Group Terlipressin Product Portfolio
8.2.5 Hangzhou Huadi Group Recent Developments
8.3 Hybio Pharmaceutical
8.3.1 Hybio Pharmaceutical Comapny Information
8.3.2 Hybio Pharmaceutical Business Overview
8.3.3 Hybio Pharmaceutical Terlipressin Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Hybio Pharmaceutical Terlipressin Product Portfolio
8.3.5 Hybio Pharmaceutical Recent Developments
8.4 Xi 'an langene biological technology
8.4.1 Xi 'an langene biological technology Comapny Information
8.4.2 Xi 'an langene biological technology Business Overview
8.4.3 Xi 'an langene biological technology Terlipressin Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Xi 'an langene biological technology Terlipressin Product Portfolio
8.4.5 Xi 'an langene biological technology Recent Developments
8.5 Shanghai Soho-Yiming Pharmaceuticals
8.5.1 Shanghai Soho-Yiming Pharmaceuticals Comapny Information
8.5.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
8.5.3 Shanghai Soho-Yiming Pharmaceuticals Terlipressin Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Shanghai Soho-Yiming Pharmaceuticals Terlipressin Product Portfolio
8.5.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
8.6 SGPharma
8.6.1 SGPharma Comapny Information
8.6.2 SGPharma Business Overview
8.6.3 SGPharma Terlipressin Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 SGPharma Terlipressin Product Portfolio
8.6.5 SGPharma Recent Developments
8.7 Maya Biotech
8.7.1 Maya Biotech Comapny Information
8.7.2 Maya Biotech Business Overview
8.7.3 Maya Biotech Terlipressin Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Maya Biotech Terlipressin Product Portfolio
8.7.5 Maya Biotech Recent Developments
8.8 EVER Pharma
8.8.1 EVER Pharma Comapny Information
8.8.2 EVER Pharma Business Overview
8.8.3 EVER Pharma Terlipressin Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 EVER Pharma Terlipressin Product Portfolio
8.8.5 EVER Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Terlipressin Value Chain Analysis
9.1.1 Terlipressin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Terlipressin Production Mode & Process
9.2 Terlipressin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Terlipressin Distributors
9.2.3 Terlipressin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.